Efficacy of Nirmatrelvir-Ritonavir versus Azvudine for COVID-19 Treatment in Tibet: A Retrospective Study.
Xiang ZhaoYuan ChengMeng ZhangBianba QiandaBaima ZhoumaBianba YangzhenYao ZhengShuo ZhangHuiying ZhaoPublished in: Infection and drug resistance (2023)
Azvudine is generally as effective as nirmatrelvir-ritonavir, but for patients with mild COVID-19, nirmatrelvir-ritonavir could suppress the virus more rapidly. For those who cannot be treated with nirmatrelvir-ritonavir, azvudine might be an effective therapy for COVID-19.